Pediatric Cold & Cough Syrup Franchise in Ahmedabad

Phenylephrine Chlorpheniramine Dextromethorphan Syrup Supplier in Mumbai

Pediatric Allergy & Cough Syrup Distributor in Delhi

Child Respiratory Pharma Franchise in Bangalore

Cold & Cough Syrup Stockist in Hyderabad
Pediatric Syrup Manufacturer & Exporter in Chandigarh

Home/Products /phenylephrine-2-5mg-5ml-chlorpheniramine-maleate-5mg-5ml-syrup

Cufstik Dx Junior Syrup

Composition : Phenylephrine (2.5mg/5ml) + Chlorpheniramine Maleate (1mg/5ml) + Dextromethorphan Hydrobromide (5mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 60ml

Price : ₹99/-

Cufstik Dx Junior Syrup contains Phenylephrine 2.5 mg/5 ml, Chlorpheniramine Maleate 1 mg/5 ml, and Dextromethorphan Hydrobromide 5 mg/5 ml, a triple-action pediatric formulation designed to relieve cold, cough, nasal congestion, and allergy symptoms in children.

Phenylephrine acts as a nasal decongestant, reducing swelling in nasal passages to ease breathing. Chlorpheniramine provides antihistaminic relief from allergy symptoms like sneezing and runny nose, while Dextromethorphan suppresses dry cough, improving comfort and rest.

Clinically, Cufstik Dx Junior Syrup is indicated for common cold, allergic rhinitis, cough, and upper respiratory tract infections, providing effective symptomatic relief and faster recovery in pediatric patients.

The syrup formulation ensures easy administration, accurate dosing, and high pediatric compliance, making it ideal for routine use in pediatric clinics, general practice, and child healthcare centers.

Read More

About the Product

Cufstik Dx Junior Syrup contains Phenylephrine 2.5 mg/5 ml, Chlorpheniramine Maleate 1 mg/5 ml, and Dextromethorphan Hydrobromide 5 mg/5 ml, a triple-action pediatric formulation designed to relieve cold, cough, nasal congestion, and allergy symptoms in children.

Phenylephrine acts as a nasal decongestant, reducing swelling in nasal passages to ease breathing. Chlorpheniramine provides antihistaminic relief from allergy symptoms like sneezing and runny nose, while Dextromethorphan suppresses dry cough, improving comfort and rest.

Clinically, Cufstik Dx Junior Syrup is indicated for common cold, allergic rhinitis, cough, and upper respiratory tract infections, providing effective symptomatic relief and faster recovery in pediatric patients.

The syrup formulation ensures easy administration, accurate dosing, and high pediatric compliance, making it ideal for routine use in pediatric clinics, general practice, and child healthcare centers.

Common side effects may include drowsiness, mild gastrointestinal upset, headache, or restlessness. Rarely, allergic reactions, rapid heartbeat, or excitability may occur, particularly in sensitive children.

Cufstik DX Junior Syrup is indicated for relief of nasal congestion, sneezing, runny nose, and dry cough associated with common cold, allergic rhinitis, and upper respiratory tract infections in children.

Use Cufstik DX Junior Syrup strictly as directed by a pediatrician. Do not exceed the recommended dose. Avoid use in children under the age recommended by the physician. Inform your doctor of any heart disease, high blood pressure, or glaucoma. Discontinue use and seek medical attention if severe adverse reactions occur.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep the bottle tightly closed and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation